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ABSTRACT
Objectives To investigate whether delirium motor 
subtypes differ in terms of phenomenology and 
contributory aetiology.
Design Cross- sectional study.
Setting International study incorporating data from Ireland 
and India across palliative care, old age liaison psychiatry 
and general adult liaison psychiatry settings.
Participants 1757 patients diagnosed with delirium 
using criteria from the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth edition (DSM IV).
Primary and secondary outcome 
measures Hyperactive, mixed and hypoactive delirium 
subtypes were identified using the abbreviated version 
of the Delirium Motor Subtype Scale. Phenomenology 
was assessed using the Delirium Rating Scale Revised. 
Contributory aetiologies were assessed using the Delirium 
Aetiology Checklist (DEC), with a score >2 indicating that 
the aetiology was likely or definitely contributory.
Results Hypoactive delirium was associated with 
dementia, cerebrovascular and systemic infection 
aetiologies (p<0.001) and had a lower overall burden 
of delirium symptoms than the other motor subtypes. 
Hyperactive delirium was associated with younger age, 
drug withdrawal and the DEC category other systemic 
aetiologies (p<0.001). Mixed delirium showed the greatest 
symptom burden and was more often associated with drug 
intoxication and metabolic disturbance (p<0.001). All three 
delirium motor subtypes had similar levels of impairment 
in attention and visuospatial functioning but differed 
significantly when compared with no subtype (p<0.001).
Conclusions This study indicates a pattern of aetiology 
and symptomatology of delirium motor subtypes across 
a large international sample that had previously been 
lacking. It serves to improve our understanding of this 
complex condition and has implications in terms of early 
detection and management of delirium.
INTRODUCTION
Delirium is a common neuropsychiatric 
condition that is independently associated 
with significantly increased morbidity and 
mortality.1 It is viewed as a unitary cognitive 
syndrome that is characterised by a heter-
ogenous neuropsychiatric presentation and 
fluctuating course.2 Despite its importance 
in terms of prognosis, it often goes undiag-
nosed or undetected in busy clinical settings.3 
This represents a significant issue in terms 
of patient care, particularly since delirium 
frequently represents a reversible condition 
and therefore its early detection and manage-
ment is vital.
The different motor presentations of 
delirium are an important factor in compli-
cating its diagnosis and treatment and have 
become the focus of efforts to improve our 
Strengths and limitations of this study
 ► This study comprised an international database with 
a large sample size.
 ► Patients from palliative care, old age liaison psychi-
atry and general adult liaison psychiatry populations 
were included.
 ► Instruments used to determine delirium motor 
subtypes and symptomatology have been widely 
validated across different populations and clinical 
settings.
 ► Limitations include the fact that this study provides 
a broad overview in terms of contributory aetiologies 
and further research is needed to investigate more 
specific aetiological findings.
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understanding of this complex condition. Lipowski4 
developed the concept of delirium motor subtypes in the 
modern era whereby he proposed two main subtypes of 
delirium, hypoactive and hyperactive, and later added 
a third distinct mixed category.5 This was expanded on 
by Liptzin and Levkoff,6 who added an operationalised 
definition of subtypes. While issues with criteria and defi-
nitions used initially led to a lack of consistency in diag-
nosis between studies,7–9 focusing on purely motor rather 
than neuropsychiatric symptoms has emerged as the most 
established method of categorisation of subtypes.10 11 This 
is supported by studies that have demonstrated that these 
subtypes can be distinguished bioelectronically by using 
motion analysis, can be identified as distinct categories 
using latent class analysis and are generally stable over 
time.12–14
Studies have demonstrated that delirium motor 
subtypes differ in terms of their symptomatology, severity 
and outcomes.10–14 Hypoactive delirium has been asso-
ciated with increased risk of mortality.15–18 However, it 
is unclear to what extent this is confounded by the rela-
tionship between hypoactive presentation and factors 
such as burden of comorbidity and medication exposure 
since many of these studies have taken place in a palli-
ative care setting. In addition, patients with hypoactive 
presentations are typically detected later and frequently 
misdiagnosed as depression, with important implications 
for patient management and prognosis.19 In contrast, 
patients with hyperactive or mixed delirium are more 
likely to receive antipsychotic medications and their 
delirium is more likely to be reversible.20 It is therefore 
important that delirium motor subtypes are accurately 
recognised in clinical practice.
Understanding symptomatology of delirium motor 
subtypes can help aid in their recognition. Studies to 
date have generally indicated that hyperactive delirium 
tends to present more often with symptoms of perceptual 
disturbance, delusions, lability of affect and motor agita-
tion21 and that thought process abnormalities and motor 
retardation are more associated with the hypoactive 
subtype.22 Some research has shown that mixed subtype is 
most severe in terms of having a greater burden of symp-
tomatology with high levels of perceptual disturbance, 
delusions, lability of affect and both motor agitation 
and motor retardation.22 Cognitive impairment is gener-
ally similar across subtypes but findings have varied.23 
However, thus far studies have been hampered by being 
confined to a particular clinical setting with a paucity of 
large- scale research to confirm their findings.
Another key question is whether delirium motor 
subtypes differ in terms of their causation. Delirium 
reflects the interaction between a variety of predisposing 
factors (eg, age, pre- existing Central nervous system 
(CNS) pathology) with precipitating insults (eg, phys-
ical illness, medication exposure, medical interventions) 
that result in the emergence of syndromal delirium. The 
aetiological underpinnings of delirium are thus complex 
and multifaceted, with typically three to four contributory 
aetiologies per episode.20 Identifying contributory aetiol-
ogies to different delirium motor subtypes is important, 
as the primary treatment of delirium involves treating its 
underlying causes. Identifying underlying causes may also 
help in the prevention of delirium, with a knock- on effect 
in terms of patient morbidity and mortality.
Despite its importance, the relationship between 
different contributory aetiologies and delirium motor 
subtype remains unclear. Some evidence indicates that 
certain aetiologies such as metabolic factors or organ 
failure are more common in hypoactive delirium, with 
substance intoxication and withdrawal more typically 
associated with the hyperactive subtype.24–27 However, 
other studies have failed to replicate these findings20 28 
and a suitably designed study (eg, sufficiently powered) 
to explore the relationship between the many different 
categories of aetiology and delirium subtype profile has 
been lacking.
The aim of the current study is to compare delirium 
motor subtypes in terms of aetiology, phenomenology 
and symptom severity using a large international data-
base derived from studies conducted across a variety of 
different clinical populations and settings.
METHODS
Patient and public involvement
No patient involvement.
Subjects and design
This study used a combined data set of existing related 
databases from two countries, Ireland20 29–34 and India.35–43 
All research took place between 2008 and 2020 inclusive. 
Raters for data included in this study were trained by 
an expert with over 20 years’ experience in the field of 
delirium research (DM), through training workshops in 
both Ireland and India using well validated assessment 
methods for these clinical populations as outlined below.
Research was conducted across three clinical settings: 
palliative care, old age liaison psychiatry and general 
adult liaison psychiatry.
Palliative care
This group consisted of consecutive referrals to a liaison 
psychiatry service in a hospice setting that were subse-
quently diagnosed as having delirium at the time of 
assessment. Research took place at Milford Hospice in 
Limerick, Ireland.30–33
Old age CL psychiatry
This group consisted of consecutive referrals to old age 
Community Liaison (CL)psychiatry services in two Irish 
Hospitals; University Hospital Limerick and University 
Hospital Galway, who were diagnosed with delirium at the 
time of assessment.20 33 34
General adult CL psychiatry
This group consisted of consecutive referrals to a general 
adult CL psychiatry service at the Post Graduate Institute 
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for Medical Research in Chandigarh, India, who were 
diagnosed with delirium at the time of assessment.35–43
Assessment
Delirium diagnosis
Delirium was diagnosed by the psychiatric teams according 
to Diagnostic and Statistical Manual of Mental Disorder-
sfourth edition (DSM IV)44 criteria using all available 
clinical information including patient assessment and 
collateral information from nursing staff, family and the 
patient’s medical records.
Dementia diagnosis
Dementia status was determined according to (1) a pre- 
existing diagnosis, or (2) on the basis of detailed history 
and examination taking in aspects such as the patient’s 
functional ability, neuroimaging and cognitive decline 
prior to assessment and was made in accordance with DSM 
IV. Cognitive decline prior to assessment was assessed 
using the Short Form of the Informant Questionnaire 
on Cognitive Decline in the Elderly (Short IQCODE),45 
which was administered to the patient’s next of kin or 
main carer.
The IQCODE comprises a 16- item informant question-
naire comparing the individual’s ability on day- to- day 
items with their performance 10 years ago. Items are 
scored by the rater from 1=much improved, 3=unchanged 
to 5=much worse. Items include aspects of daily life such 
as the ability to remember conversations that happened 
the previous day, address and telephone numbers and 
where things are kept. Scores are added up and divided 
by the total number of questions (n=16). The resultant 
score ranges from 1 to 5. All databases in this analysis 
that used the IQCODE score to aid in dementia diagnosis 
used a cut- off of ≥3.5 to signify likely dementia. This was 
then combined with all relevant clinical information to 
make a diagnosis.
Delirium motor subtypes
Delirium motor subtypes were differentiated using the 
abbreviated version of the Delirium Motor Subtype 
Scale (DMSS-4).11 The DMSS-4 was developed from the 
longer, 13- item, Delirium Motor Subtype Scale (DMSS)46 
using latent class analysis to show the four symptoms 
that best differentiated the subtypes from the original 
DMSS.11 It comprises two items denoting hyperactivity 
(increased activity and loss of control of activity) and two 
items denoting hypoactivity (decreased speed of actions 
and decreased amount of speech), with mixed subtype 
defined as the presence of both hyperactive and hypoac-
tive criteria over the previous 24- hour period. No subtype 
describes a presentation in which neither the criteria for 
hyperactive nor hypoactive delirium are fulfilled. The 
DMSS-4 was developed for quick and accurate identifica-
tion of delirium motor subtype in busy clinical practice 
and has shown a good concordance with the original 
DMSS and has been widely validated across a variety of 
populations and clinical settings.11 29 30 34 35
Aetiology
Contributory aetiologies were identified using the 
Delirium Aetiology Checklist (DEC).47 The DEC is a 
13- item checklist that is designed to document the aetio-
logical underpinnings contributing to a delirium episode. 
Its 13 categories are: drug intoxication, drug withdrawal, 
metabolic/endocrine disturbance, traumatic brain injury, 
seizures, infection (intracranial), infection (systemic), 
neoplasm (intracranial), neoplasm (systemic), cere-
brovascular, organ insufficiency, other CNS and other 
systemic. Other CNS includes neurological conditions 
such as Parkinson’s disease and multiple sclerosis while 
other systemic includes conditions such as postoperative 
state, immunosuppression or heat stroke. These catego-
ries are present to allow the rater to list contributory aeti-
ologies that do not fit under the other 11 items.
Each aetiology is rated on a scale according to its like-
lihood of being contributory to the delirium. This scale 
ranges from 0=ruled out/not present/not relevant to 
4=definite cause. Raters can therefore document multiple 
aetiologies and their level of contribution to a particular 
episode of delirium. For the purposes of this study, DEC 
items were broken down into two categories: unremark-
able (score 0–2) and possibly/probably contributory 
(scores of 3 or 4). This also allowed for the total and mean 
number of likely contributory aetiologies to be calculated 
and compared between delirium motor subtypes.
Delirium symptomatology and severity
Delirium severity and symptomatology were measured 
using the Delirium Rating Scale Revised-98 (DRS R98).48 
The DRS- R98 is a 16- item clinician rated scale used to rate 
the severity of delirium both overall and on a broad range 
of neuropsychiatric and cognitive symptoms. It is made 
up of 13 severity items and 3 diagnostic items. Each item 
is rated 0 (absent/normal) to 3 (severe impairment), with 
descriptors attached to each severity level. The severity 
scale (items 1–13) range from a score or 0–39 with larger 
scores indicating more severe delirium. A score of over 15 
points typically indicates delirium and 18 points indicates 
delirium when dementia is present. The DRS- R98 can 
be divided into non- cognitive (items 1–8) and cognitive 
(9–13) subscales based on construct validity. It has been 
validated across clinical settings and has been shown to 
have a high inter- rater reliability, sensitivity and specificity 
at detecting delirium. It has also been used to determine 
differing symptomatology and severity across delirium 
motor subtypes.10 12
Statistical analysis
Patients with missing data for any of the variables being 
examined were excluded from our final analysis. Contin-
uous normally distributed variables are reported as 
means and SD, while categorical variables are reported 
as counts and percentages. Normally distributed data 
were compared using Analysis of variance (ANOVA), 
whereas non- parametric and categorical data were 
compared using Kruskal- Wallis and Χ2 tests, respectively. 
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Standardised adjusted residuals were used for post- hoc 
analysis of Χ2 tests, with a level of greater than 1.96 (2.0 
is used by convention) used to indicate statistical signif-
icance.49 Dunn multiple comparison test was used for 
post- hoc analysis of the Kruskal- Wallis test, while the 
Bonferroni procedure was used during post- hoc analysis 
for ANOVA. Statistical analysis was conducted using the 
SPSS V.25 package.
RESULTS
Patient demographics and dementia status
The total number of subjects after excluding missing 
data (n=176) was 1757. They comprised 1124 (64%) men 
and 633 (36%) women. This included 263 patients from 
palliative care, 287 from old age liaison psychiatry and 1207 
from general adult liaison psychiatry. Dementia status was 
listed in 1685 (98%) cases and marked as unknown or not 
listed in 72 cases. The number of patients diagnosed with 
comorbid dementia was 252 (15%). A breakdown of the 
data sets used is outlined in table 1.
As can be seen from table 1, significant differences 
exist across the databases on all parameters analysed. Old 
age liaison psychiatry were the oldest group and had the 
greatest proportion of patients with comorbid dementia, 
while general adult liaison psychiatry were the youngest 
and had the highest overall scores on the DRS- R98. The 
palliative care group had a significantly greater number 
of contributory aetiologies than the other groups.





Old age liaison 
psychiatry
(n=287)
General adult liaison 
psychiatry
(n=1207) P value
Age (mean, SD) 56.6 (20.3) 70.7 (11.3) 79.6 (8) 48.1 (17.8) <0.001
Sex (% female) 632 (36) 126 (48) 139 (48) 366 (30.3) <0.001
Dementia (total, %) 252 (14) 73 (28) 161 (56) 18 (0.01) <0.001
Hypoactive (total,%) 298 (17) 74 (28) 94 (33) 130 (11) <0.001
Mixed (total, %) 426 (24) 79 (30) 54 (19) 293 (24) <0.001
Hyperactive (total,%) 844 (48) 70 (27) 82 (29) 692 (57) <0.001
No subtype (total, %) 189 (11) 40 (15) 57 (20) 92 (8) <0.001
DRS- R98 total (mean, SD) 23.8 (7.4) 20.3 (7.1) 23.4 (7) 24.7 (7.4) <0.001
DRS- R98 severity (mean, SD) 18.4 (6.7) 16.1 (6.5) 18.9 (6.6) 18.8 (6.6) <0.001
DRS- R98 cog (mean, SD) 8.6 (3.4) 8.5 (3.3) 9.3 (3) 8.4 (3.6) <0.001
DRS- R98 non- cog (mean, SD) 9.8 (4.2) 7.6 (4.3) 9.6 (4.8) 10.4 (3.9) <0.001
Total aetiologies (mean, SD) 2.3 (1.1) 2.9 (1.4) 2.2 (1.2) 2.2 (1.1) <0.001
DRS R98, Delirium Rating Scale Revised; DRS R98 Cog, Delirium Rating Scale Revised Cognition score (items 9–13); DRS R98 non- cog, 
Delirium Rating Scale Revised non- cognitive (items 1–8); hyperactive, hyperactive delirium; hypoactive, hypoactive delirium; mixed, mixed 
delirium; no subtype, no delirium motor subtype.

































































P value is significant at <0.01.
Adj. residual value, adjusted residual value; hyperactive, hyperactive delirium; hypoactive, hypoactive delirium; mixed, mixed delirium.
5Glynn K, et al. BMJ Open 2021;11:e041214. doi:10.1136/bmjopen-2020-041214
Open access
Table 2 indicates that there were significant differences 
in mean age between the delirium motor subtypes, with 
hyperactive significantly younger and hypoactive signifi-
cantly older.
Hypoactive and no subtype were significantly associ-
ated with positive dementia status, female gender and 
palliative care and old age liaison psychiatry settings. In 
contrast, hyperactive delirium was significantly associated 
with negative dementia status, male gender and had a 
greater proportion of cases in general adult liaison psychi-
atry setting. Mixed delirium did not show any relationship 
to either gender or dementia status but was significantly 
associated with the palliative care group.
Aetiology of delirium motor subtypes
Metabolic disturbance was the most common contribu-
tory aetiology and was present in 782 (44%) of the total 
sample, followed by systemic infection in 493 (28%) and 
organ sufficiency which was listed in 336 (19%) of cases 
(see table 2). The mean number of aetiological factors 
per case was 2.11 (1.33) with more than one documented 
probable aetiology evident in 80% of cases (n=1409).
The mean and SD number of aetiologies in the different 
delirium motor subtypes were as follows: no subtype 1.16 
(1.34), hypoactive 2.46 (1.2), mixed 2.46 (1.2) and hyper-
active 2.3 (1.67). No subtype had significantly lower active 
aetiologies attributed per case.
As seen in table 3, hypoactive delirium was significantly 
associated with systemic infection, intracranial neoplasm 
and cerebrovascular aetiologies. Mixed delirium was 
significantly associated with drug intoxication and meta-
bolic disturbance and hyperactive delirium was signifi-
cantly associated with drug withdrawal and other systemic 
aetiologies. No subtype did not show any significant asso-
ciations in terms of aetiologies.
Symptomatology of delirium motor subtypes
Significant differences between delirium motor subtypes 
were found for all items on the DRS- R98 scale (see 
table 4). Patients with hyperactive delirium scored higher 


























































































































































P value is significant at <0.01.
*Total patients: note that several aetiologies can be listed for each patient.
Adj. residual value, adjusted residual value (this needs to explicitly stated somewhere- as to what does this mean); hypoactive, hypoactive 
delirium; mixed, mixed delirium.
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on severity of symptoms than those with hypoactive 
delirium and no subtype across most items, excluding 
motor retardation. However, severity of symptoms were 
not significantly different between hyperactive and mixed 
subtypes across several items (only statistically significant 
differences between pairwise comparisons are shown). 
Patients with mixed subtype had significantly greater 
total severity score than both hypoactive and hyperactive 
subtypes. As expected, patients with hypoactive delirium 
showed significantly greater severity of motor retarda-
tion (item 8) than hyperactive delirium and the opposite 
pattern was true for motor agitation (item 7).
In terms of cognition, hypoactive, mixed and hyperac-
tive subtypes score significantly higher than no subtype 
on totals for cognitive scores (items 9–13). All subtypes 
(hypoactive, mixed, hyperactive) scored significantly 
greater in terms of impairment on visuospatial ability 
(item 13) and attention (item 10) than the no subtype 
group.
DISCUSSION
This analysis of a large international sample across 
multiple clinical settings (palliative care, old age liaison 
and general adult liaison psychiatry referrals) identified 
that delirium motor subtypes differ in respect of aetiology, 
neuropsychiatric symptom severity and demographic 
factors such as age and gender. This work emphasises 
the typically multifactorial nature of delirium causation, 
whereby there are typically two to three active aetiological 
factors in any case and where single aetiology delirium 
is the exception. These observations further enhance 
understanding of this complicated condition with impli-
cations for delirium recognition and management.
There was a significant difference between delirium 
motor subtypes in age, dementia status and gender. 
Patients with hypoactive delirium were more likely to 
be of older age, women and have comorbid dementia 
compared with those with hyperactive presentations. They 
were also more common in old age liaison psychiatry and 
palliative care settings. While previous research has found 
that hypoactive delirium tends to be more common in 
older patients,8 9 this is the first time such an association 
has been documented in a large sample incorporating 
different clinical settings. This is important, as hypoactive 
delirium is associated with greater mortality and is often 
missed or misdiagnosed, particularly in older patients.19
Despite its association with an increased risk of mortality 
in previous research, hypoactive delirium was rated as 
Table 4 Mean (SD) DRS- R98 items for the different delirium motor subtypes (note that larger values indicate greater symptom 
severity)








IV X2 P value
Post- hoc
significant pairs*
1. Sleep disturbance 1.72 (0.8) 2.17 (0.7) 2.21 (0.78) 1.53 (0.9) 166.5 <0.001 III>I, II>I, IV<II, III
2. Perceptual disturbance 0.71 (1.1) 1.30 (1.2) 1.4 (1.2) 0.7 (1.1) 135.2 <0.001 III>I, II>I, IV<II, III
3. Delusions 0.43 (0.8) 0.64 (0.9) 0.57 (0.9) 0.26 (0.6) 48.3 <0.001 III>I, II>I, IV<II, III
4. Lability of affect 0.91 (0.8) 1.26 (0.9) 1.24 (0.9) 0.57 (0.7) 125.7 <0.001 III>I, II>I, IV<I, II, III
5. Language 0.90 (0.9) 1.22 (0.9) 1.27 (1) 0.71 (0.8) 90.3 <0.001 III>I, II>I, IV<II, III
6. Thought process 1.34 (1.8) 1.31 (0.9) 1.37 (1) 1 (0.83) 20.9 <0.001 IV<I, II, III
7. Motor agitation 0.83 (0.9) 1.63 (0.9) 2.1 (1.1) 0.92 (1) 447.8 <0.001 III>II>I, III>I, IV<II, III
8. Motor retardation 1.29 (0.9) 1.27 (1) 0.29 (0.7) 0.52 (0.8) 509.4 <0.001 I>III, II>III, IV<I, II, III
9. Orientation 1.53 (0.9) 1.92 (0.8) 2 (0.8) 1.3 (1.1) 144.7 <0.001 III>II>I, IV<II, III
10. Attention 1.98 (0.9) 2.21(0.8) 2.1 (0.8) 1.7 (1) 53.5 <0.001 IV<I, II, III
11. Short- term memory 1.68 (0.9) 1.82 (0.9) 1.85 (1) 1.55 (1) 20.3 <0.001 III>I, IV<II, III
12. Long- term memory 1.12 (1) 1.31 (1) 1.24 (1.1) 0.8 (0.9) 43.5 <0.001 II>I, IV<I, II, III
13. Visuospatial ability 1.47 (1) 1.64 (1.1) 1.56 (1.1) 1.15 (1.1) 31.4 <0.001 IV<I, II, III
14. Temporal onset 1.82 (0.9) 2.1 (0.7) 2.3 (1) 1.74 (1) 94 <0.001 III>II>I, III>I, IV<II, III
15. Fluctuation 0.97 (0.6) 1.41 (0.6) 1.65 (0.8) 0.80 (0.8) 272 <0.001 III>II>I, II>I, IV<II, III
16. Physical disorder 1.66 (0.4) 1.82 (0.4) 1.87 (0.4) 1.67 (0.5) 82.1 <0.001 III>I, II>I, IV<II, III
Non- cognitive (i1–8) 8.12 (4.1) 10.8 (3.6) 10.4 (4.1) 6.22 (3.6) 275.8 <0.001 III>I, II>I, IV<I, II, III
Cognitive (9–13) 7.76 (3.2) 8.88 (3.4) 8.44 (3.5) 6.45 (3.3) 101.7 <0.001 III>I, II>I, IV<I, II, III
Severity (1–13) 15.81 (6.1) 19.67 (5.9) 19.26 (6.8) 12.62 (5.6) 38.9 <0.001 III<II>I, IV<I, II, III
DRS- R98 total (1–16) 20.30 (6.9) 25 (6.4) 25.1 (7.6) 16.95 (6.7) 259.4 <0.001 III>I, II>I, IV<I, II, III
*Only significant differences at the level of p<0.01 are shown.
DRS, Delirium Rating Scale; DRS- R98, DRS Revised; hyperactive, hyperactive delirium; hypoactive, hypoactive delirium; mixed, mixed 
delirium.;
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having a lower overall burden of delirium symptoms on 
the DRS- R98 than mixed or hyperactive subtypes in the 
current study. One possible explanation for this finding 
is that those with hyperactive delirium are younger, more 
physically able and are more likely to come to the atten-
tion of staff and are more florid in terms of neuropsy-
chiatric symptoms such as delusions and hallucinations. 
This notion is supported by previous research, which 
has shown that those with hyperactive delirium were 
more likely to receive antipsychotic medication.22 Mixed 
delirium had the greatest severity scores and burden of 
symptomatology which is a likely reflection of the fact 
that they include diagnostic criteria for both hypoactive 
and hyperactive subtypes. This is consistent with previous 
findings in the area.9
Delirium symptoms can be divided into neuropsychi-
atric (involving sleep, motor behaviour and psychosis) 
and cognitive. Of note, the three motor subtypes differed 
in terms of the former but had similar levels of distur-
bance in respect of attention and visuospatial function 
which are key neuropsychological domains in delirium. 
This is in keeping with previous findings that suggest that 
delirium subtypes have a consistent cognitive profile but 
differ in respect of other non- cognitive symptoms, empha-
sising that it is a cognitive disorder with disturbances to 
attention and visuospatial function representing core 
elements. This supports the use of tests of attention and 
visuospatial ability for reliable and consistent detection of 
delirium, including all of its presentations. In addition, 
the majority of patients with full syndromal delirium have 
evidence of discernible alterations in motor behaviour 
such that those with no motor subtype differed in respect 
of overall delirium symptom severity (including less 
severe cognitive disturbance), suggesting that many of 
these patients have mild or subsyndromal illness.
While attributing aetiologies to particular delirium 
subtypes is challenging due to the multifactorial nature of 
the condition, the current study aimed to give an overview 
of likely contributory aetiologies by breaking them down 
into 13 categories using the DEC. Hypoactive delirium 
was significantly associated with systemic infection, intra-
cranial neoplasm and cerebrovascular aetiologies when 
compared with other delirium motor subtypes. This is 
clinically important as delirium can be the principal 
presenting feature for a variety of acute medical emer-
gencies such as sepsis and stroke.50 This study emphasises 
the need to maintain a high level of vigilance regarding 
the multifactorial nature of delirium causation as well as 
the possibility of silent background aetiologies.
This finding is in contrast to previous research, which 
has principally indicated an association between hypoac-
tive delirium and metabolic factors and organ failure.25–28 
One possible explanation for this discrepancy is that 
much of this previous research has taken place in palli-
ative care settings and therefore may lead to a dispro-
portionate representation of particular aetiologies (eg, 
organ failure, neoplasm). The current study overcomes 
this issue by including data from multiple clinical settings 
with a larger sample and is therefore more likely to give 
more accurate and generalisable results.
Of the contributory aetiologies identified, only drug 
withdrawal and other systemic causes were significantly 
associated with hyperactive subtype. Withdrawal from 
certain drugs, particularly alcohol, benzodiazepines and 
opiates are known to cause hyperactivity and agitation 
and our results confirm a well- established link between 
hyperactive delirium and drug withdrawal. The category 
of other systemic aetiologies includes postoperative states, 
the effects of radiation treatment or other rarer causes 
such as hypothermia. Future research is needed to clarify 
which of these other systemic causes is most associated 
with the hyperactive delirium subtype.
This study has several limitations. While the study is 
large and incorporates data from two countries, a mix 
of old age and adult liaison psychiatry referrals and 
palliative care assessments may not be a broad enough 
cross- section of patients to be truly generalisable. For 
example, delirium presentations in other setting such as 
ICU may differ in terms of aetiology and subtype. There 
was also a relatively high proportion of the sample that 
had no delirium motor subtype, despite being diagnosed 
with DSM IV delirium. This raises the question as to 
whether this group in fact had subsyndromal delirium 
and requires further investigation in future research. 
While the DEC has good face validity and has been used 
in much previous research, it has not been fully validated 
and it is unknown the degree to which it is affected by 
inter- rater reliability issue. It is also not an exhaustive list 
in terms of contributory aetiologies and only provides a 
broad overview of the likely contributory factors involved 
in the episode of delirium (eg, metabolic disturbance 
and drug intoxication are broad categories that each 
encompasses many causes of each). The cross- sectional 
study design may also not be ideal when studying a condi-
tion that fluctuates considerably and a longitudinal case 
design may provide better insights into how complex 
etiological underpinnings evolve over the course of an 
episode of delirium.
In conclusion, the current study indicates a pattern of 
aetiologies and symptomatology across delirium motor 
subtypes using a large combined international database. 
The association between hypoactive delirium, dementia, 
cerebrovascular disease and infection is an important 
insight for clinical practice, where these individuals may 
often be overlooked. Mixed delirium has the greatest 
symptom burden, combining both hypoactive and 
hyperactive features and is associated with drug intoxi-
cation and metabolic aetiologies. Those with hyperactive 
delirium are significantly younger, more likely to be men 
and more likely to be suffering the effects of drug with-
drawal. This is, to the best of the authors knowledge, the 
first time such a large international database has been 
used to examine differences in delirium motor subtypes 
and it provides useful knowledge on this complex and 
often misdiagnosed condition.
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